Tin tức & Cập nhật
Xem bài viết Ung thư
Xem
Chỉ hiển thị Multimedia

Baseline NLR predicts risk of severe CIP in patients with NSCLC
17 Sep 2026
bởiStephen Padilla
A high neutrophil-to-lymphocyte ratio (NLR; ≥4.75) at baseline appears to contribute to an elevated risk of developing severe checkpoint inhibitor pneumonitis (CIP) in patients with nonsmall cell lung cancer (NSCLC), suggests a study.
17 Sep 2026

Add-on tafasitamab–lenalidomide improves PFS in BCLs
09 Sep 2026
bởiAudrey Abella
In the global phase III frontMIND study, adding tafasitamab and lenalidomide (Tafa-Len) to an R-CHOP* chemotherapy regimen significantly improves progression-free survival in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade BCL (HGBCL).
09 Sep 2026

Tebentafusp delivers 5-year survival benefit in metastatic uveal melanoma
08 Sep 2026
bởiStephen Padilla
Long-term survival benefits with tebentafusp persist in previously untreated HLA-A∗02:01-positive patients with unresectable or metastatic uveal melanoma (mUM), as shown in the longest survival follow-up of a phase III trial.
08 Sep 2026





